Fritextsökning
Artiklar per år
Innehållstyper
-
Eli Lilly writes biotech fine history
The American biotech company Eli Lilly will pay US 1.415 billion to resolve allegations of off-label promotion of a dementia drug.
-
Crafoord Prize to an American and two Japanese
Today the Royal Swedish Academy of Sciences announces the laureates of the Crafoord Prize in Polyarthritis 2009.
-
Parnevik firm in Swiss osteoporosis deal
The golf legend Jesper Parnevik's drug delivery firm EffRx has signed a license agreement with Nycomed for a new drug against osteoporosis.
-
Collaboration brings next generation drugs
Wyeth and Santaris Pharma announce a new alliance to develop RNA-based medicines.
-
Prenatal testing breakthrough
For the first time specific gene expression information from fetal cells isolated from maternal blood samples is available.
-
Medicult acquires embryo scanner
The Danish company Medicult signs an agreement with Novocellus to gain access to embryo selection technology.
-
Glucose facilitates the use of indigo
The Finnish researcher Anne Vuorema oat the MTT Agrifood Research Finland proves in her new doctoral dissertation that glucose can serve as a reducing agent of indigo.
-
Academy for a new turn at work
Are you qualified within life science, but unemployed? Here is your chance for a new career, in high demand.
-
Meda gets access to Asia
The biotech giant Meda has recently acquires world-wide rights to the cancer breakthrough pain drug Onsolis.
-
Pfizer buys Swiss vaccines
Pfizer executes commercial license agreements for novel human vaccines based on the Swiss company Cytos Biotechnology's Immunodrug technology.
-
Fat cells' reaction differs with body weight
The fat cells of overweight people may react differently to dietary changes than in their lean peers, according to a pioneering study from the Dutch organization TNO Quality of Life.
-
New tools to fight bacteria
Better guidelines for doctors, detailed patient journals, and national monitoring systems are some of the tools needed to combat the increasing problem of antibiotic-resistant bacteria. That is stated in a report commissioned by the Swedish government.
-
Martin Bergö: "The Idea is the Thing"
researchers. It isn't the first award for the Associate Professor at Gothenburg University's Sahlgrenska Academy. In 2007, he received a grant award of 16 million SEK from the European Research Council for his pioneering work.
-
Time to save for survival
The future is bright for the biotech industry. However, the companies need to cut costs immediately if they want to survive the rough economic times.
-
Ambassador program makes MVA big in Japan
The first ambassadors of the Medicon Valley Ambassador Programme have only worked in each other's countries for six months. But they have already made a significant difference for their sister clusters.
BREAKING